Single award · contract

BARDA Will Implement a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Trial in the US to…

Award ID: 75A50124C00001

FY2024 · complete year · data as of 2026-07-03

A single federal award, with both ends of the trail linked.

$117.4M
Total award value

Award 75A50124C00001 is a contract from the Department of Health and Human Services, $117.4M obligated, FY2024 to FY2030, for BARDA Will Implement a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Trial in…. The work is performed in North Carolina. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN12 (Health R&D Services; Health Care Services; Applied Research). Source

Description

BARDA Will Implement a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Trial in the US to Evaluate the Safety and Efficacy of Novel Host-Directed Therapeutic Candidates in Hospitalized Adults with Ards.

Award details

Award typeContract
PIID75A50124C00001
Action date2023
Period81 mo
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceNorth Carolina →
Competed?Not recordedSource
Total (exact)$117,399,278

More from Department of Health and Human Services

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.